HDAC Inhibitors as Novel Anti-Cancer Therapeutics. (Q38381829)

scientific article published on January 2015

Language	Label	Description	Also known as
English	HDAC Inhibitors as Novel Anti-Cancer Therapeutics.	scientific article published on January 2015

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

25782916

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25782916%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

review article

1 reference

stated in

Europe PubMed Central

title

HDAC Inhibitors as Novel Anti-Cancer Therapeutics (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

25782916

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25782916%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1

1 reference

stated in

Europe PubMed Central

PubMed ID

25782916

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25782916%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

author name string

Biswa Prasun Chatterji

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

25782916

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25782916%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

publication date

1 January 2015

1 reference

stated in

Europe PubMed Central

PubMed ID

25782916

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25782916%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

published in

Recent Patents on Anti-Cancer Drug Discovery

1 reference

stated in

Europe PubMed Central

PubMed ID

25782916

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25782916%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

volume

10

1 reference

stated in

Europe PubMed Central

PubMed ID

25782916

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25782916%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

issue

2

1 reference

stated in

Europe PubMed Central

PubMed ID

25782916

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25782916%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

page(s)

145-162

1 reference

stated in

Europe PubMed Central

PubMed ID

25782916

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25782916%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 March 2020

Identifiers

DOI

10.2174/1574892810666150317144511

1 reference

stated in

Europe PubMed Central

PubMed ID

25782916

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25782916%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

Europe PubMed Central

PubMed ID

25782916

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25782916%20AND%20SRC:MED&resulttype=core&format=json

HDAC Inhibitors as Novel Anti-Cancer Therapeutics. (Q38381829)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

HDAC Inhibitors as Novel Anti-Cancer Therapeutics. (Q38381829)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search